EPISODE · Nov 11, 2017 · 5 MIN
Recently Approved Drugs: Pembrolizumab for cHL
from ASCO Education
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
Embed this episode
NOW PLAYING
Recently Approved Drugs: Pembrolizumab for cHL
0:00
5:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of ASCO Education?
This episode is 5 minutes long.
When was this ASCO Education episode published?
This episode was published on November 11, 2017.
Can I download this ASCO Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!